ArticleAmerican journal of translational research2024

Clinical effectiveness and safety of Camrelizumab immunotherapy in treating advanced esophageal carcinoma.

Yusheng Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.